Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
|
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
Revenues: |
UNITED STATES | 9,514 | 10,864 | 11,119 | 10,666 | 11,233 | 7,684 | 7,979 | 7,412 |
Japan | 1,017 | 1,167 | 1,132 | 1,028 | 947 | 934 | 900 | 811 |
GERMANY | 813 | 1,027 | 978 | 890 | 943 | 899 | 866 | 850 |
Other | 762 | 986 | 948 | 874 | 947 | 887 | 902 | 916 |
Total revenues [+] | 12,106 | 14,044 | 14,177 | 13,458 | 14,070 | 10,404 | 10,647 | 9,989 |
Products | | | | | | | | 9,989 |
Revenue growth [+] | -13.8% | -0.9% | 5.3% | -4.3% | 35.2% | -2.3% | 6.6% | -4.9% |
UNITED STATES | -12.4% | -2.3% | 4.2% | -5.0% | 46.2% | -3.7% | 7.6% | -2.7% |
Japan | -12.9% | 3.1% | 10.1% | 8.6% | 1.4% | 3.8% | 11.0% | |
GERMANY | -20.8% | 5.0% | 9.9% | -5.6% | 4.9% | 3.8% | 1.9% | -15.3% |
Cost of goods sold [+] | 835 | 875 | 867 | 844 | 970 | 659 | 7,615 | 7,092 |
Cost of product sales | | | | | | | 6,908 | 6,393 |
Gross profit | 11,271 | 13,169 | 13,310 | 12,614 | 13,100 | 9,745 | 3,032 | 2,897 |
Gross margin | 93.1% | 93.8% | 93.9% | 93.7% | 93.1% | 93.7% | 28.5% | 29.0% |
Selling, general and administrative | 1,945 | 1,930 | 1,885 | 1,758 | 1,897 | 1,188 | 1,190 | 1,078 |
Equity in earnings | -1 | -94 | -156 | -160 | -162 | -200 | -68 | -178 |
Other operating expenses | 8,325 | 9,252 | 9,291 | 8,899 | 9,209 | 6,789 | | |
EBITDA [+] | 1,000 | 1,893 | 1,978 | 1,797 | 1,832 | 1,568 | 1,774 | 1,641 |
EBITDA growth | -47.2% | -4.3% | 10.1% | -1.9% | 16.8% | -11.6% | 8.1% | -10.7% |
EBITDA margin | 8.3% | 13.5% | 14.0% | 13.4% | 13.0% | 15.1% | 16.7% | 16.4% |
Depreciation | 158 | 185 | 199 | 220 | 211 | 176 | 171 | 153 |
EBITA | 842 | 1,708 | 1,779 | 1,577 | 1,621 | 1,392 | 1,603 | 1,488 |
EBITA margin | 7.0% | 12.2% | 12.5% | 11.7% | 11.5% | 13.4% | 15.1% | 14.9% |
Amortization of intangibles | 323 | 352 | 363 | 386 | 426 | 549 | 703 | 550 |
EBIT [+] | 519 | 1,356 | 1,416 | 1,191 | 1,195 | 843 | 900 | 938 |
EBIT growth | -61.7% | -4.2% | 18.9% | -0.3% | 41.8% | -6.3% | -4.1% | -19.8% |
EBIT margin | 4.3% | 9.7% | 10.0% | 8.8% | 8.5% | 8.1% | 8.5% | 9.4% |
Non-recurring items [+] | 2,561 | 363 | | 1,167 | 33 | | | |
Asset impairment | 3,081 | 363 | | 1,167 | 33 | | | |
Loss (gain) on sale of assets | -520 | | | | | | | |
Interest expense | 456 | 468 | 408 | 374 | 381 | 355 | 363 | 360 |
Interest expense | 456 | 468 | 408 | 374 | 381 | 355 | 363 | 360 |
Other income (expense), net [+] | 190 | 113 | 43 | -272 | 102 | 562 | 554 | 238 |
Gain (loss) on sale of assets | | 10 | 224 | -1 | 1 | 410 | 9 | 110 |
Gain (loss) on investments | 41 | 99 | -110 | -251 | 76 | 145 | 414 | |
Other | 70 | -6 | -32 | 6 | -7 | 7 | 131 | 14 |
Pre-tax income | -2,308 | 638 | 1,051 | -622 | 883 | 1,050 | 1,091 | 816 |
Income taxes | 224 | 217 | -203 | -217 | 60 | -985 | 316 | 185 |
Tax rate | | 34.0% | | 34.9% | 6.8% | | 29.0% | 22.7% |
Minority interest | 62 | 81 | 58 | 51 | 48 | 46 | 39 | 42 |
Earnings from continuing ops | -2,594 | 340 | 1,196 | -456 | 775 | 1,989 | 736 | 589 |
Earnings from discontinued ops | | | | | 141 | 452 | 499 | 280 |
Net income | -2,594 | 340 | 1,196 | -456 | 916 | 2,441 | 1,235 | 869 |
Net margin | -21.4% | 2.4% | 8.4% | -3.4% | 6.5% | 23.5% | 11.6% | 8.7% |
|
Basic EPS [+] | ($6.83) | $0.84 | $2.88 | ($1.08) | $1.68 | $4.47 | $1.55 | $0.95 |
Growth | -909.1% | -70.7% | -367.3% | -164.1% | -62.5% | 189.1% | 62.0% | |
Diluted EPS [+] | ($6.77) | $0.82 | $2.84 | ($1.08) | $1.67 | $4.44 | $1.53 | $0.94 |
Growth | -926.7% | -71.2% | -364.1% | -164.5% | -62.5% | 190.2% | 62.1% | |
|
Shares outstanding (basic) [+] | 380 | 403 | 416 | 424 | 462 | 445 | 476 | 617 |
Growth | -5.7% | -3.1% | -1.9% | -8.2% | 3.8% | -6.5% | -22.9% | |
Shares outstanding (diluted) [+] | 383 | 415 | 421 | 424 | 465 | 448 | 481 | 624 |
Growth | -7.7% | -1.4% | -0.7% | -8.8% | 3.8% | -6.9% | -22.9% | |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|